Biology Reference
In-Depth Information
Thriemer, K., et al., 2010. Azithromycin combination therapy for the treatment of uncom-
plicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical
trial. J. Infect. Dis. 202 (3), 392-398.
Tjitra, E., et al., 2002. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and
chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to
Plasmodium vivax
dhfr mutations. Antimicrob. Agents Chemother. 46, 3947-3953.
Tjitra, E., et al., 2008. Multidrug-resistant
Plasmodium vivax
associated with severe and fatal
malaria: a prospective study in Papua, Indonesia. PLoS Med. 5 (6), e128.
Valecha, N., et al., 2001. Comparative antirelapse efficacy of CDRI compound (80/53 (bula-
quine) vs primaquine in double blind clinical trial. Curr. Sci. 80 (4), 561-563.
van den Broek, I.V., et al., 2005. Efficacy of chloroquine + sulfadoxine-pyrimethamine,
mefloquine + artesunate and artemether + lumefantrine combination therapies to treat
Plasmodium falciparum
malaria in the Chittagong Hill Tracts, Bangladesh. Trans. R. Soc.
Trop. Med. Hyg. 99 (10), 727-735.
Van den Eede, P., et al., 2011.
Plasmodium vivax
sub-patent infections after radical treatment
are common in Peruvian patients: results of a 1-year prospective cohort study. PLoS One
6 (1), e16257.
van Vugt, M., et al., 1998. Randomized comparison of artemether-benflumetol and arte-
sunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antimicrob.
Agents Chemother. 42 (1), 135-139.
van Vugt, M., et al., 1999. Efficacy of six doses of artemether-lumefantrine (benflumetol)
in multidrug-resistant
Plasmodium falciparum
malaria. Am. J. Trop. Med. Hyg. 60 (6),
936-942.
Villegas, L., et al., 2007. Chloroquine prophylaxis against vivax malaria in pregnancy: a ran-
domized, double-blind, placebo-controlled trial. Trop. Med. Int. Health 12 (2), 209-218.
White, N., 1999. Antimalarial drug resistance and combination chemotherapy. Philos. Trans.
R. Soc. Lond. B 354, 739-749.
White, N.J., 2008. The role of anti-malarial drugs in eliminating malaria. Malar. J. 7
(Suppl. 1), S8.
White, N.J., 2011. Determinants of relapse periodicity in
Plasmodium vivax
malaria. Malar.
J. 10, 297.
Wilairatana, P., et al., 1999. Efficacy of primaquine regimens for primaquine-resistant
Plasmo-
dium vivax
malaria in Thailand. Am. J. Trop. Med. Hyg. 61 (6), 973-977.
World Health Organization, et al., 2009. Malaria Rapid Diagnostic Test Performance: Results
of WHO Product Testing of Malaria RDTs: Round 1 (2008). World Health Organiza-
tion, Geneva.
World Health Organization, 2010. Guidelines for the Treatment of Malaria. World Health
Organization.
